1. Wei, Wei, Zeng, Qingxuan, Wang, Yan, Jiang, Jiandong, Song, Danqing. 2022. Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. In Acta pharmaceutica Sinica. B, 13, 2138-2151. doi:10.1016/j.apsb.2022.12.009. https://pubmed.ncbi.nlm.nih.gov/37250154/
2. Ge, Lan, Zhang, Yuhong, Zhao, Xingwang, Zhang, Yi, You, Yi. 2021. EIF2AK2 selectively regulates the gene transcription in immune response and histones associated with systemic lupus erythematosus. In Molecular immunology, 132, 132-141. doi:10.1016/j.molimm.2021.01.030. https://pubmed.ncbi.nlm.nih.gov/33588244/
3. Waller, Sophie E, Morales-Briceño, Hugo, Williams, Laura, Tchan, Michel, Fung, Victor S C. 2021. Possible EIF2AK2-Associated Stress-Related Neurological Decompensation with Combined Dystonia and Striatal Lesions. In Movement disorders clinical practice, 9, 240-244. doi:10.1002/mdc3.13384. https://pubmed.ncbi.nlm.nih.gov/35146062/
4. Wei, Siwei, Wu, Lei, Xiang, Zhen, Jiang, Liubing, Du, Zhen. 2024. EIF2AK2 protein targeted activation of AIM2-mediated PANoptosis promotes sepsis-induced acute kidney injury. In Renal failure, 46, 2403649. doi:10.1080/0886022X.2024.2403649. https://pubmed.ncbi.nlm.nih.gov/39311631/
5. Kuipers, Demy J S, Mandemakers, Wim, Lu, Chin-Song, Bertoli-Avella, Aida M, Bonifati, Vincenzo. 2020. EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia. In Annals of neurology, 89, 485-497. doi:10.1002/ana.25973. https://pubmed.ncbi.nlm.nih.gov/33236446/
智鼠故事 
